Round Table Discussion: Biomarkers in Immuno-oncology – From Preclinical Approaches Through Clinical Trials

Time: 4:00 pm
day: Day One


  • Discuss various biomarker platforms/technologies for preclinical immuno-oncology studies
  • Discuss how the use of biomarkers in preclinical immuno-oncology studies can provide guidance for clinical studies
  • Discuss biomarker approaches for immuno-oncology clinical trials